Table 1.
Cohort characteristics | NCCN (n = 1650) | BCCA (n = 1138) |
---|---|---|
Male gender | 54% | 60% |
Age (y), mean (SD) | 57 (16) | 63 (15) |
Age >60 y, % | 46% | 60% |
LDH ratio >1, % | 50% | 49% |
Ann Arbor stage (III-IV), % | 59% | 55% |
ECOG PS (≥2), % | 11% | 37% |
Extranodal disease,* % | 36% | 25% |
Lymphomatous involvement in the bone marrow, CNS, liver/GI tract, or lung.